ASEAN Heart Journal

Intended for healthcare professional

Original Paper

ASEAN Heart Journal

April 2014, 22:5

First online: 21 May 2014

Original Paper

Thought Leadership on Thrombotic Disorders in South East Asia

Mark Y. Chan MBBS, MHS1
Open Access
This content is freely available to anyone, anywhere at any time.
  • Summary
  • Supplementary Material
  • References
  • About this Article

Abstract

Thrombosis is a leading cause of morbidity and mortality, not only in aging industrialized countries, but also many emerging economies(1).

Keywords

Percutaneous Coronary Intervention - Primary Percutaneous Coronary Intervention - Bivalirudin - Direct Thrombin Inhibitor - Clinical Trial Unit


This article is distributed under the terms of the Creative Commons Attribution License (CC-BY 4.0) which permits any use, distribution, and reproduction in any medium, provided the original author(s) and the source are credited.
Asean Heart Journal http://​www.​aseanheartjourna​l.​org/​
​© The Author(s) 2014. This article is published with open access by Asean Federation of Cardiology
Correspondence to: Mark Y. Chan, MBBS, MHS Associate Professor of Medicine, Yong Loo Lin School of Medicine National University of Singapore Senior Consultant Cardiologist, National University Heart Centre, National University Health System. Tel: 6772 5538 Fax: 6872 2998 Email: [email protected]

Supplementary Material

Nil

 

References

1.http://www.who.int/mediacentre/factsheets/fs310/en/index.html (accessed 6-1-2014).

2. http://www.portola.com/Anticoagulant-Market (accessed 6-1-2014).

3. http://www.nrdo.gov.sg/uploadedFiles/NRDO/Publications/20110211%20AMI%20Information%20Paper%202010%20v3.pdf (accessed 6-1-2014).

4. http://www.moh.gov.sg/content/moh_web/home/costs_and_financing/HospitalBillSize.html (accessed 6-1-2014).

5. Cho Yeow Koh, Maria Kazimirova, Adama Trimnell, Peter Takac, Milan Labuda, Patricia A. Nuttall, and R. Manjunatha Kini: Variegin, a Novel Fast and Tight Binding Thrombin Inhibitor from the Tropical Bont Tick. Journal of Biological Chemistry, 282, 40, 29101–29113.

6. http://​www.​cardiosource.​org/​Science-And-Quality/​Clinical-Trials/​H/​HEAT-PPCI.​aspx (accessed 17-4-2014)

7. Tan Huay Cheem, Heparin has No Place as an Anticoagulant in PCI – A Protagonist’s View, ASEAN Heart Journal, Springer Global Science Journals, Vol.22, no.1, 14-18 (2014).

8. Kim Moo Hyun, Opposition: Unfractionated heparin should no longer be used in the catheterization laboratory, ASEAN Heart Journal, Springer Global Science Journals, Vol.22, no.1, 38-41 (2014).

9. Chee Yen Lin, New Oral Anticoagulants, ASEAN Heart Journal, Springer Global Science Journals, Vol.22, no.1, 30-37 (2014).

10. Alan Fong, Thrombin and FXa plasma concentration levels in patients with atrial fi brillation on long term warfarin therapy, ASEAN Heart Journal, Springer Global Science Journals, Vol.22, no.1, 20-29 (2014)

About this Article

Title
Thought Leadership on Thrombotic Disorders in South East Asia


Open Access
Available under Open Access


Journal >> 22:1


Online Date
21 November 2019


DOI
10.7603/s40602-014-0004-2


Online ISSN
2315-4551


Publisher
ASEAN Federation of Cardiology


Additional Links Cardiology


Keywords
Percutaneous Coronary Intervention
Primary Percutaneous Coronary Intervention
Bivalirudin
Direct Thrombin Inhibitor
Clinical Trial Unit


Author Affiliations
1. National University Heart Centre, Singapore, Singapore


Correspondence to:
Mark Y. Chan,[email protected]